New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method
PL412706A1
Method for extending durability of 2-pyridynyl thermolabile protective groups and the compounds for this method
PL422094A1
Molecule of nucleic acid, expression cartridge, expression vector, eukaryotic host cell, transgenic mammal, method for inducing RNA interference in eukaryotic host and application of a molecule of nucleic acid in the therapy of diseased induced by CAG-type trinucleotide repeat expansion
PL403341A1
"hammerhead" type ribozymes, composition, comprising a therapeutic agent, their use and the process for miR21 hydrolysis and miR21 precursor
PL402440A1
Modified human gene activation induced cytidine deaminase B cells (AID), a modification of the human AID gene, preparation having an activity of AID and methods of preparing this formulation in a bacterial system
PL401324A1
Vaccine against Lyme disease, a genetic construct, the recombinant protein, the method for preparing a genetic construct, a method of preparing a vaccine, a method of preparing a recombinant protein, the use of recombinant proteins for the manufacture of a vaccine against Lyme borreliosis
PL400248A1
New process for the synthesis of polyphosphates (2)
PL399003A1
Method for protecting the hydroxyl or amine functions or thiol, the new compounds for the implementation of this method and the method of preparation of the new compounds
PL390769A1
Cytosine analogue, process for the preparation of cytosine analogue, DNA methyltransferase 1 inhibitor, method for DNA methylation inhibition, the use of analog in the treatment of diseases involving deviations from the standard DNA methylation
